Jasper Edgar Neggers

CSO and co-founder of Promakhos. In high school, Jasper built a web-shop. He obtained a BSc, MSc and PhD in Biomedical Sciences from KU Leuven. He pioneered the use of XPO1 inhibitors for treating cancer and invented a CRISPR-directed evolution technology for drug target deconvolution. Jasper then joined the Dana-Farber Cancer Institute & Broad Institute of MIT and Harvard to identify and validate new drug targets for gastrointestinal cancers. Now, he develops drugs for chronic inflammation.